Supplemental material
Infectious Diseases
Volume 54, 2022 - Issue 5
Original Articles
Clinical characteristics and outcomes in hospitalized adult influenza patients: an observational study from Norway 2014–2018
Torgun Wæhrea Department of Infectious Diseases, Oslo University Hospital, Oslo, Norway;b K. G. Jebsen Centre for Influenza Vaccine Research, University of Oslo, Oslo, Norway
https://orcid.org/0000-0001-5895-5027View further author information
https://orcid.org/0000-0001-5895-5027View further author information, Gro Tunheimb K. G. Jebsen Centre for Influenza Vaccine Research, University of Oslo, Oslo, Norway;c Division of Infection Control, Norwegian Institute of Public Health, Oslo, NorwayCorrespondence[email protected]
https://orcid.org/0000-0002-8280-8243View further author information
https://orcid.org/0000-0002-8280-8243View further author information, Johanna Eva Bodinb K. G. Jebsen Centre for Influenza Vaccine Research, University of Oslo, Oslo, Norway;c Division of Infection Control, Norwegian Institute of Public Health, Oslo, Norwayhttps://orcid.org/0000-0001-6556-3486View further author information
https://orcid.org/0000-0001-6556-3486View further author information, Ida Laakec Division of Infection Control, Norwegian Institute of Public Health, Oslo, Norwayhttps://orcid.org/0000-0002-0546-896XView further author information
https://orcid.org/0000-0002-0546-896XView further author information, Dag Kvalea Department of Infectious Diseases, Oslo University Hospital, Oslo, Norway;b K. G. Jebsen Centre for Influenza Vaccine Research, University of Oslo, Oslo, Norway;d Institute of Clinical Medicine, University of Oslo, Oslo, Norwayhttps://orcid.org/0000-0001-6410-2530View further author information
https://orcid.org/0000-0001-6410-2530View further author information, Anne-Marte Bakken Krane Department of Medical Microbiology, Oslo University Hospital, Oslo, Norwayhttps://orcid.org/0000-0003-3056-9137View further author information
https://orcid.org/0000-0003-3056-9137View further author information, , , Fredrik Oftungb K. G. Jebsen Centre for Influenza Vaccine Research, University of Oslo, Oslo, Norway;c Division of Infection Control, Norwegian Institute of Public Health, Oslo, Norwayhttps://orcid.org/0000-0003-2913-9666View further author information
https://orcid.org/0000-0003-2913-9666View further author information, Siri Mjaalandb K. G. Jebsen Centre for Influenza Vaccine Research, University of Oslo, Oslo, Norway;c Division of Infection Control, Norwegian Institute of Public Health, Oslo, Norwayhttps://orcid.org/0000-0002-3870-5861View further author information
https://orcid.org/0000-0002-3870-5861View further author information & Anne Margarita Dyrhol-Riisea Department of Infectious Diseases, Oslo University Hospital, Oslo, Norway;b K. G. Jebsen Centre for Influenza Vaccine Research, University of Oslo, Oslo, Norway;d Institute of Clinical Medicine, University of Oslo, Oslo, Norwayhttps://orcid.org/0000-0003-4009-4032View further author information
https://orcid.org/0000-0003-4009-4032View further author information show all